• Nenhum resultado encontrado

Cell therapy in experimental model of inflammatory bowel disease

N/A
N/A
Protected

Academic year: 2017

Share "Cell therapy in experimental model of inflammatory bowel disease"

Copied!
8
0
0

Texto

(1)

w w w . j c o l . o r g . b r

Journal

of

Coloproctology

Original

Article

Cell

therapy

in

experimental

model

of

inflammatory

bowel

disease

Mônica

Yonashiro

Marcelino

a

,

Natália

Langenfeld

Fuoco

a

,

Ana

Elise

Valencise

Quaglio

b

,

Renata

Aparecida

de

Camargo

Bittencourt

c

,

Bruna

Cambraia

Garms

d

,

Thaís

Helena

da

Motta

Conceic¸ão

e

,

Luiz

Claudio

Di

Stasi

b

,

João

Tadeu

Ribeiro-Paes

e,∗

aInstituteofBiomedicalSciences,UniversidadedeSãoPaulo,SãoPaulo,SP,Brazil

bDepartmentofPharmacology,BiosciencesInstitute,UniversidadeEstadualPaulista,Botucatu,SP,Brazil

cInstituteofHealthSciences,UniversidadePaulista,Assis,SP,Brazil

dSchoolofBiologicalandEnvironmentalSciences,UniversidadeFederaldaGrandeDourados,Dourados,MS,Brazil

eDepartmentofBiologicalSciences,UniversidadeEstadualPaulista,Assis,SP,Brazil

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received15January2014 Accepted5March2014 Availableonline2July2014

Keywords:

Inflammatoryboweldisease Stemcells

Adiposetissue Celltherapy

a

b

s

t

r

a

c

t

Inflammatoryboweldisease,whichmainlyinvolvesCrohn’sdiseaseandulcerative recto-colitis,isaninflammatoryconditionofthemucosathatcanafflictanysegmentofthe gastrointestinaltract.Despitethefactthattheexistingtherapiesresultinimprovementin patient’ssymptomatologyandqualityoflife,thereisnocurativetreatment.Surgical treat-mentinvolvescomplexproceduresassociatedwithhighmorbidityandmortalityrates.In thiscontext,celltherapywithstemcellshasemergedasatreatmentwithbroad poten-tialapplicability.In thisstudy,weintended toverify the efficacyoftransplantationof adiposetissue-derivedstemcellsinratswithintestinalinflammationinducedby trini-trobenzenesulfonicacid.Thecellpopulationwasisolatedfromtheadiposetissueofinguinal regionofrats andprocessedforculturebymechanicaldissociation. Theanimalswere evaluatedwith respectto clinicalandbiochemicalaspects, aswellas bymacroscopic, microscopicandhistologicalanalyses.Intheexperimentalmodelofbowelinflammation by2,4,6-trinitrobenzenesulfonicacid,theinfusionofadiposetissuesignificantlyreduced thepresenceofadhesionsinthecolonandadjacentorgansanddecreasedtheactivityof myeloperoxidase,amarkerofneutrophilinfiltrationintheinjuredmucosa.Theresults sug-gestthatcelltherapywithadiposetissuecanpromoteand/oracceleratetheregenerationof damagedintestinalmucosa.Itisconcludedthatthepresenceofadhesionsandthe deter-minationofmyeloperoxidaseactivityprovideindicationsthatadiposetissuecanpromote and/oracceleratetheregenerationofinflammatorybowelmucosa.

©2014SociedadeBrasileiradeColoproctologia.PublishedbyElsevierEditoraLtda.All rightsreserved.

StudyconductedatDepartmentofBiologicalSciences,UniversidadeEstadualPaulista(UNESP),AssisCampus,Assis,SP,Brazil.

Correspondingauthor.

E-mail:jtrpaes@yahoo.com.br,joao.paes@pq.cnpq.br(J.T.Ribeiro-Paes). http://dx.doi.org/10.1016/j.jcol.2014.06.004

(2)

Terapia

celular

em

modelo

experimental

de

doenc¸a

inflamatória

intestinal

Palavras-chave:

Doenc¸aInflamatóriaIntestinal Células-tronco

TecidoAdiposo TerapiaCelular

r

e

s

u

m

o

ADoenc¸aInflamatóriaIntestinal(DII),consistindoprincipalmentedadoenc¸adeCrohne retocoliteulcerativa,éumacondic¸ãoinflamatóriadamucosaquepodeacometerqualquer segmentodotratogastrointestinal.Apesardasterapiasexistentesresultaremnamelhora dossintomasedaqualidadedevidadospacientes,nãohánenhumtratamentocurativo. Otratamentocirúrgicoenvolveprocedimentoscomplexosassociadosaaltastaxasde mor-bimortalidade.Nestecontexto,aterapiacelularcomcélulas-troncodespontacomoopc¸ão detratamentopotencialmentepromissora.Emfunc¸ãodestesaspectos,pretendeu-se,no presenteestudo,verificaraeficáciadotransplantedecélulas-troncoderivadasdotecido adiposo(ASC)emratoscominflamac¸ãointestinalinduzidaporácido trinitrobenzenosul-fonico(TNBS).AsASCsforamobtidaspordissociac¸ãomecânicadotecidoadiposodaregião inguinalderatoseprocessadasparacultivo.Osanimaisforamavaliados,considerando-se osaspectosclínicosebioquímicos,além deanálisesmacroscópica,microscópicae his-tológica.Nomodelodeinflamac¸ãointestinalinduzidaporTNBS,ainfusãodeASCsreduziu significativamenteapresenc¸adeaderênciasentreocóloneórgãosadjacentes,bemcomo diminuiuaatividadedamieloperoxidase(MPO),ummarcadordainfiltrac¸ãodeneutrófilos namucosalesada.OsresultadosobtidospermitemconcluirqueaterapiacelularcomASCs podepromovere/ouaceleraroprocessoderegenerac¸ãodamucosaintestinalinflamada.

©2014SociedadeBrasileiradeColoproctologia.PublicadoporElsevierEditoraLtda. Todososdireitosreservados.

Introduction

Inflammatoryboweldisease(IBD)comprisestwonosological entitiesofchronicandrecurrentnature:Crohn’sdisease(CD) andulcerativerectocolitis(URC).1CDisatransmural

inflam-matoryconditionofmucosathatcanaffectanysegmentofthe gastrointestinaltract.2,3UnlikeCD,URCisadisease

character-izedbydiffuseinflammationofcolonicmucosa.URCaffects therectum(95%ofcases)andproximalportionsofthecolon, inasymmetricandcontinuousmanner.4,5

Despite the introduction of new clinical therapeutic approachesandtheircontributiontoimprovethequalityof lifeofpatientswithIBDand/orinthepreventionofrecurrence, thereisnodefinitiveclinicalcurativetreatment.Thesurgical treatment,inturn,involvescomplexprocedures associated withhighratesofmorbidityandmortalityandpostoperative complications.6,7

Severalstudieshaveshownthatmesenchymalstemcells (MSC) may be involved in tissue regeneration, since they havetheabilitytomodulatetheimmuneresponsesof pro-inflammatorycells toinduce anenvironment witha more tolerant phenotype to inflammation.8–11 Furthermore, it is

proposedthatthesecellsactinregulatingtheimmunesystem ininflammatorytissues,puttingintoactionproinflammatory cytokinesandthesecretionofchemokines.12Thus,itcanbe

postulatedthatMSCcouldexertananti-inflammatoryaction inresponsetotheinductionofinjuryinexperimental mod-elsinvivoand,thus,actingasapotentialtherapeuticagentin inflammatorydiseasessuchasURCandCD.

Inlight ofthis, inthis study we intendedto verify the effectivenessoftransplantationofMSCderivedfromadipose

tissue(ASC)inratswithintestinalinflammationinducedby trinitrobenzenesulfonic acid (TNBS). In addition, with this approach we intend to shed light on pathophysiological aspectsofIBD,aswellastosuggestandevaluatethe effec-tivenessofnewalternativetherapies.

Method

Animals

Inthisstudy,Wistaralbinorats(Rattusnorvegicus),raisedinthe CentralBioterium,UNESP–campusofAssis,wereusedunder controlledtemperature(22◦C)andlighting(12hoflight/12hof darkness)conditionsandfedwithasoliddietsupplemented withVitagold®(Tortuga,SaoPaulo,Brazil).

Experimentalgroups

The animals were divided into the followingexperimental groups:blank(healthyanimals),control(animalswith TNBS-inducedbowelinflammationandtreatedwithphosphate–PBS buffer)andtreated(animalswithTNBS-inducedbowel inflam-mationandtreatedwithmesenchymalstemcells)groups.

Isolationbymechanicaldissociationandcultureof adiposetissue-derivedstemcells

The adipose tissue extracted from the groin of rats was mechanically dissociated with the help of two L-shaped syringe needles (BDTM, New Jersey, USA) in RPMI 1640

(3)

antibiotic/antimycotic(Gibco®,NewYork,USA)forcell/tissue

separation. Then, the solution containing dissociated cells wasfilteredthrougha70␮m-filter(CellStrainer–BDFalconTM,

NewJersey,USA)forseparatingcellulardebris.Thecollected materialwascentrifugedfor10minat900×g.Then,thecells wereseededinALPHA-MEMmedium(Gibco®,NewYork,USA)

supplementedwith20%FetalCalfSerum–FCS(Gibco®,New

York,USA)and1%antibiotic/antimycotictoafinal concentra-tionof1×105cells/cm2andincubatedat37Cin5%CO

2.Cells

weremaintainedincultureand,whena60–80%confluencein relationtotheculturedishareawasreached,weredissociated withTrypleTM(Gibco®,NewYork,USA).

Invitrodifferentiationofadiposetissue-derivedstemcells

Inordertoinduceosteogenic,chondrogenicandadipogenic differentiation, specifickits (StemPro® Gibco®, New York,

USA) were used, according to manufacturer’s instructions. Theosteogenicdifferentiationwasconfirmedbyanalysisof thematerialstainedwithAlizarinRedS(Sigma–Aldrich®,St.

Louis,MO,USA),thechondrogenicdifferentiationwithAlcian Bluedye(Sigma–Aldrich®, St.Louis,MO,USA),andthe

adi-pogenicdifferentiation withOilRedO (Sigma–Aldrich®,St.

Louis,MO,USA).

ExperimentalmodelofIBD

Theinductionofthebowel inflammatoryprocess was per-formedbythemethoddescribedbyMorrisetal.,13withminor

modifications. 2,4,6-Trinitrobenzenesulfonic acid – TNBS (Sigma–Aldrich®,St.Louis,MO,USA)wasfirstlyophilizedand

subsequently preparedtoobtain asolutionof40mg/mLin 50%ethanol(v/v).Bowelinflammatoryprocessinductionwas performed by intracolonic administration of 0.25mL TNBS solutionatapoint8cmfromtherectum.Theanimalsinthe blankgroupunderwentthesameprocedure,butwith admin-istrationofPBSreplacingTNBS.Allanimalswere sacrificed sevendaysaftertheinductionofIBD.

Celltransplantation

Thecell infusionwas performedby intravenousroute (tail vein).Inthetreatedgroup,1mLofthecellsolutiondiluted inPBSataconcentrationof1×107cells/mLwasinfused.The

controlgroupreceivedasimilartreatment;however,onlyPBS wasinfused.

Evaluationofanti-inflammatorybowelactivity

Theanimalswereevaluated,consideringfoodconsumption, bodyweightandonsetofdiarrhealstools.Attheendofthe experiment,thecolonswereextractedandanalyzedforbowel damage.

Macroscopicanalysis

Theweightand lengthofthe colonand presenceof adhe-sionsinthebowelandsurroundingorganswereevaluated.An

analysisofseverityandextentofbowelinjury,accordingtoa scalepreviouslydescribedbyBelletal.,14wasalsoperformed.

Biochemicaldeterminations

Thedeterminationoftotalglutathione(GSH)contentwas per-formed according tothe method described by Anderson,15

andthedeterminationofmyeloperoxidase(MPO)activityin ratcolonfragmentswasperformedbythemethodofKrawisz etal.16

Histologicanalysis

Immediatelyafterthemacroscopicevaluationofthecolonic inflammatoryprocess,tissuesamples(0.5mm)adjacenttothe injuredareawerecollectedforhistologicalprocessing.These sampleswereplacedinhistologicalcassettes,fixedin4% for-malinandstainedwithhematoxylin–eosin(HE).

Statisticalanalysis

Resultswereexpressedasmean±standarddeviation. Differ-ences between means were tested byanalysis of variance (ANOVA), followed by tests of significance. Nonparametric data (scores) were expressed as median and analyzed by Kruscal–Wallistest.Discontinuousdatawereanalyzedby chi-squared(X2)test.Statisticalsignificancewasconsideredwhen

p<0.05.

Ethicalaspects

ThisstudywasapprovedbytheEthicsCommitteeontheUse ofAnimals(CEUA),UniversidadeEstadualPaulista–UNESP,

campusofAssis(RegistrationNo.012/2011).

Results

Cultureandcharacterizationofadiposetissue-derived stemcells

AsshowninFig.1A,onday7ofcultureasignificantpopulation ofcellswithanelongated,fusiformappearancewasobserved. A70–80%confluencewasachievedaroundthe11thdayof cul-ture(Fig.1B).AfterthefirstdissociationprocesswithTryple®

(Gibco®, New York, USA), the cell growth became faster,

becausethe70–80%confluencelevelwasreachedwithin3–4 days.Itwasalsoobservedthat,afterthethirdpassage,the culturehadassumedtheappearanceofauniformmonolayer ofspindlecells(Fig.1C), indicatingthatprobablytherewas no contaminationwithnon-adherent cells,suchasmature adipocytesanderythrocytes.

To verifywhether the cells isolated fromadipose tissue (ASC) met the requirements established by the Interna-tional Society of Cellular Therapy for validation of MSC,17

(4)

A

B

C

Fig.1–Behaviorofadiposetissue-derivedstemcellsatdifferentperiodsofculture.(A)Primaryculture(7days);(B)after11 days(70–80%confluence);and(C)homogeneousmonolayerofcellswithfibroblastoidaspect(thirdpassage).

Fig.2–DifferentiationofASCintochondrocytes,osteocytes andadipocytes.(A)CultureofASCintheabsenceofan inductionmedium(20×);(B)proteoglycanssynthesizedby chondrocytesandstainedwithAlcianBlue(40×);(C)bone matrixstainedwithAlizarinRedS(40×);and(D)lipid vacuolesstainedwithOilRedO(40×).

staining (Fig. 2C). Finally, the differentiation of ASC into adipocyteswasproven.AsseeninFig.2D,lipidvacuolesare stainedinred.

Evaluationofbowelanti-inflammatoryactivity

Thefood intake showed that the average consumption by healthy animals was higher, when compared with control

group animals. The consumption of blank group animals was statisticallydifferent,comparedtocontroland treated groups.However,therewasnostatisticallysignificant differ-encebetweencontrolandtreatedgroups.

Thedailybodyweightevaluationshowedthat,duetothe reductionoffoodconsumption,therewasadecreaseinbody weightofanimalssubjectedtotheadministrationofthe alco-holicsolutionofTNBS.Themeandeltabodyweightofblank groupshowedstatisticallysignificantdifference,when com-paredtocontrolandtreatedgroups.However,therewasno statisticallysignificantdifferencebetweentreatedandcontrol groups.

Thepresenceofdiarrhealstoolswasdailymonitoredin allgroupsofanimals.Withrespecttocontrolgroupanimals, anincidenceof100%wasobserved,whereasintreatedgroup animals the incidencewas 90%.An analysisofthe results showednostatisticallysignificantdifferencebetweencontrol andtreatedgroups.

Macroscopicevaluation

Colonweight/length(W/L)

There is a relationship for colonic injury resulting from inflammation,andthiscanbequantitativelyexpressedbyan increaseincolonicweight/lengthratio(W/Linmg/cm).With respecttotheresultspresentedinTable1,wenotedthatthere wasnostatisticallysignificantdifferenceinrelationtocolonic W/Lbetweencontrolandtreatedgroups.

Adhesions

Presenceofadhesionsintheintestineandsurroundingorgans isalsoconsideredacharacteristicfeatureofbowelmucosa inflammation.Table1shows 83.33%ofadhesionincontrol groupanimalsand20%inASC-treatedanimals.Astatistically

Table1–Macroscopicparametersfromtreatmentwithadiposetissue-derivedstemcells(ASC)inanexperimentalmodel ofinflammatoryboweldisease,byadministeringanalcoholicsolutionofTNBS.

Group Score(0–10)a Injuryextent(cm)b Weight/lengthratio(mg/cm)b Adherence(%)c

Blank 0a 0a 106.77±3.241a 0a

Control–PBS 7(5–9)b 3.70±0.741b 269.57±43.851b 83.33b

TreatedwithASC 6.5(4–9)b 3.51±0.415b 199.36±27.85b 20c

a Thescorevaluesareexpressedasmedian(range).

b Injuryextentandcolonicweight/lengthratioareexpressedasmean±SEM(standarderrorofthemean).

(5)

significantdifferencebetweencontrolandtreatedgroupswas found.

Severityandextentofbowelinjury

TheadministrationofTNBSincontrolgroupanimalstriggered aninflammatoryprocesscharacterizedbylesionsalongthe colon,between1.20and5.50cminlengthandascorebetween 5and9(Table1).Theresultsshownostatisticallysignificant differenceinrelationtothelesionlengthanditsscoreamong PBS–controlgroupanimalsversusASC-treatedanimals.

Biochemicalanalysis

The animals treated with the alcoholic solution of TNBS showed a statisticallysignificant difference in regard to a reduction in glutathione levels, when compared to blank groupanimals. AlthoughGSH levelswerehigher intreated animals,therewasnosignificantdifferencewhenconfronting theresultsamongPBS-treatedversusASC-treatedanimals.

Inthecaseofmyeloperoxidase(MPO)activity,itwasfound that the treatment with adipose tissue-derived stem cells resulted ina statisticallysignificant difference in terms of enzymeactivity,whencomparedtocontrolgroup,ascanbe seeninFig.3.

Histologicalanalysis

Fig.4Ashowsthenormalcoloniccytoarchitectureofahealthy animal, where the cells are intact, and mucosal, submu-cosalandmuscularismucosalayersandtheirdimensionsare

Blank PB S

Treatment

0 200 400 600 800 1000

***

*

MPO (U/g of tissue) a

b

c

Fig.3–Assessmentoftheactivityofmyeloperoxidase (MPO)inintestinalmucosaofaninflammatorybowel diseaseanimalmodel.Dataareexpressedasmean±SEM. Valueswithoutlettersincommondifferatp<0.05.

clearlyidentified,withoutanykindofmorphologicalchange. Fig. 4Bdepicts the colon ofan animal with TNBS-induced inflammatoryprocess,characterizedbymucosal disruption and the presence of abnormal cells as to form, size and number comparedtohealthy animals.Additionally, alarge submucosalcellinfiltrate,typicalofneutrophilmigrationdue tocolonicinflammation,isperceived.Fig.4Cdepictsthecolon

(6)

ofananimalundergoingtreatmentwithASC,wherealarge cellularinfiltrateduetoTNBS-inducedcolonicinflammation isnoted.However,thereisnomucosaldisruption–an occur-renceclearlyseeninPBS-treatedanimals.Themucosalcells arenotsignificantlyalteredinshape,andaclearrecoveryof coloniccytoarchitecturecanbeperceived.

Discussion

and

conclusion

Stemcellsderivedfromadiposetissue(ASC)havebeenused experimentally asa potentially promising alternative ther-apyinanumberofdiseases.Thetherapeuticeffectofstem cellsisattributabletoaprobableimmunomodulatoryaction, withsuppressionorinhibitionoftheinflammatoryprocess, aswellasbyangiogenesisstimulation.8–12,18Inthiscontext,

IBDcanbeincludedinthegroupofdiseases thatcan ben-efitfromcelltherapywithstemcells.TheASCusedinthis studywasidentifiedasapopulationofelongated,fusiform cells,acharacteristicfeatureofMSCandshowingplastic sur-faceadherence.Furthermore,ASCpresented,wheninspecific conditionsofinduction,thefunctionalpropertyof differen-tiationin vitro inchondrogenic, osteogenicand adipogenic lineages,consistentwithvalidationcriteriareportedbyother authorsanddefinedbytheInternationalSocietyforCellular Therapy.11,17

Theenzymaticdigestionbyusingcollagenaseiscurrently the most widely used procedure for obtaining and isolat-ingASC.18,19 Inthisstudy,weusedaninnovativeandnovel

techniqueofmechanicaldissociationforASCisolationand culture.Itshouldbeemphasizedthatthemechanical dissoci-ationmakesunnecessarytheuseofcollagenase,maintaining theefficiencyoftheprocessandbeingcheaper.

Itiswellestablishedthatoneofthesymptomsofpatients sufferingIBDisareductioninbodyweight,consideringthat thereisadecreaseinfoodintake,besidestheoccurrenceof gastrointestinal disturbances.20 Areductionin foodintake,

withconsequentweightlossoftheanimalsafterthe induc-tionofIBD,wasseenincoliticgroups.However,itwasfound thatfoodintakeanddecreaseofbodyweightinASC-treated animals were similar to those for control group animals. According to Morris et al.,13 the IBD induction model by

TNBS/ethanolproducesintestinalwallulcerationand thick-ening, without affectingsignificantly the long-term weight increaseofanimals.Thus,the needforalonger periodfor restorationofnormalfoodintakeand,thus,bodyweight,is inferred.

Commonly,diarrheaoccurswithaninflammationofthe colonandsmallintestine,asaresultfromtheactionof inflam-matorymediatorsinbowelepithelium.21 Theoccurrenceof

thisobservationparameter,acharacteristicfeatureofIBD,was observedin90%ofASC-treatedgroupanimals,showingthat, after7daysoftreatment,thereisstillalargeamountof inflam-matorymediatorsinthecolon.Thesedataraisethepossibility thattheperiodforassessingtheeffectivenessofcelltherapy asanalternativetreatmentforIBDshouldbeextendedbeyond the7-dayperiodadoptedinthisstudy.

Otherindicatorsofseverityandextentofinjuryresulting fromIBDare:increaseinweightanddecreaseincoloniclength inanimalswithbowel inflammation.11,13,22Thereisaclear

differenceinmeanW/Lratio,astheTable1shows.However, therewasnostatisticallysignificantdifferencebetween ani-malstreatedwithstemcellsversuscontrolanimals(Table1). This effect is possibly due to the severe injury caused by theadministrationofthealcoholicsolutionofTNBS,thereby complicatingtheregeneratingprocessoftheinjuredmucosa. Andoetal.11reportedthataninjectionofASCdirectlybeneath

thecolonsubmucosasignificantlydecreasestheweightofthe inflamed colon. Thisisanindicationthatthe location and routeofcelladministrationcaninfluencethefinaloutcome ofatreatment,aspreviouslyreportedbyotherauthors.23,24In

thisstudyweadoptedanIVinfusionrouteforASC,sothat thedivergenceamongtheresultsofthisstudyandofthose reportedbyAndoetal.11couldberelatedtothedifferent

infu-sionrouteusedinthestudy.

ItisalsopossibletoevaluatetheintensityofIBDlesion severity by its length and scoring.25 Table 1 shows that

thecolonicdamagecausedbytheinfusionofalcohol/TNBS wassevereandextensive,makingtherecoveryofintestinal mucosaunlikely after7daysofASCinfusion.In2009, Wei et al.26 compared theinfusionof hematopoieticstem cells

(HSC),bonemarrowstemcells(MSC)andamixtureofbothcell typesinratswithTNBS-inducedcolitisafter7,14and21days. Theauthorsfoundthatadecreaseinthelesionscoreoccurred onlyonday21.Furthermore,this resultwas onlyobserved inthegrouptreatedwithaHSC/MSCcombination.Thus,we caninferthat,duetotheintensityandextentoftheinjury, itwouldbenecessarytoincreasethetimeperiodtoevaluate thestemcellperformancewithrespecttotheabilitytoreduce inflammationandpromoteregenerationoftheinjuredtissue. Anotherpointtobeconsideredreferstothepossibilityofa HSC/MSCco-infusion,consideringthatthesynergisticeffect ofthesedifferentcelltypescanactinabeneficialwayinthe treatmentofanumberofdiseases.27,28

The presence of adhesions among the colon and sur-rounding organs and/or tissues as a result of transmural inflammationisacommonfeatureofIBD,especiallyinCD.29

Table1showstheoccurrenceofasignificantreductioninthe incidenceofadhesionsincoliticanimalsandinASC-treated animals compared withcontrol group animals, suggesting that ASCacted asanagentprotecting and/orreducing the inflammatoryprocess.

Itcanbenotedthatinexperimentalmodelsofintestinal inflammationbyinstillationofTNBS,GSHdepletionresulting fromcolonicinflammationoccurred.22,25,30

ItcanbeseenthattheASCsuseddidnotpresentpotential topromoteincreasedlevelsofGSH.Itisnoteworthythatno studyonhumansoranimalmodelswithintestinal inflamma-tionrecordingdosagesoftotalglutathionelevelsafterinfusion ofstemcellshasbeenpublished.

Amongthebiochemicalanalyzes,myeloperoxidase(MPO) is an important tool for identifying the presence of neu-trophilic infiltrates and for revealing an inflammatory process as a result of the colonic inflammation. It is known that MPO levelreflects the quantityof neutrophils, and a decrease in its activity reflects a decrease in the injured tissue inflammation.16 In the present study, it

(7)

anti-inflammatoryagent,diminishingthedamagecausedby TNBSadministration.11,30

The presence of adhesions and the determination of myeloperoxidaseactivityprovideanindicationthatASChave theabilitytopromoteand/oracceleratetheregeneration pro-cessininflamedintestinalmucosae.However,methodological adjustmentsshould beincluded infuture projects. Among thepropositions ofreadjustment,thereshouldbeincluded anevaluationoftheeffectivenessofcelltherapyforalonger periodoftime;cellinfusionbyotherroutesofadministration, inadditiontointravenousroute;andfeasibilityofthistherapy throughco-infusionofASCinassociationwithhematopoietic stemcells(HSC).

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

Acknowledgments

The authors thank the Mayor of Assis and its City Coun-cil (SP – Brazil) and the Consórcio Intermunicipal do Vale doParanapanema(CIVAP/Health)forfinancialsupport.The authorsMonicaYonashiroMarcelinoandNataliaLangenfeld FuocowerefundedbytheCoordenac¸ãodeAperfeic¸oamento dePessoaldeNívelSuperior(CAPES–Brazil).

r

e

f

e

r

e

n

c

e

s

1. Almeida-PoradaG,SolandM,BouraJ,PoradaCD.Regenerative medicine:prospectsforthetreatmentofinflammatorybowel disease.RegenMed.2013;8:631–44.

2. LindayJO,ChipperfieldR,GilesA,WheelerC,OrchardT.AUK retrospectiveobservationalstudyofclinicaloutcomesand healthcareresourceutilisationofinfliximabtreatmentin Crohn’sdisease.AlimentPharmacolTher.2013;38:52–61. 3. BaumgartDC,SandbornWJ.Inflammatoryboweldisease:

clinicalaspectsandestablishedandevolvingtherapies. Lancet.2007;369:1641–57.

4. FiteA,MacfarlaneS,FurrieE,BahnamiB,CummingsJH, SteinkeDT,etal.Longitudinalanalysesofgutmucosal microbiotasinulcerativecolitisinrelationtopatientageand diseaseseverityandduration.JCM.2013;51:849–56.

5. KornbluthA,SacharDB,MACG.PracticeParameters CommitteeoftheAmericanCollegeofGastroenterology. Ulcerativecolitispracticeguidelinesinadults:American CollegeofGastroenterology,PracticeParametersCommittee. AmJGastroenterol.2010;105:501–23.

6. ShafferVO,WexnerSD.SurgicalmanagementofCrohn’s disease.LangenbecksArchSurg.2013;398:13–27. 7. OrsiPR[dissertac¸ão(MestradoemCiênciasBiológicas)]

Efeitossinérgicosdapaepalantina,umaisocumarinaisolada doscapítulosfloraisdePaepalanthusbromelioides,sobrea atividadedasulfassalazinanomodelodecoliteulcerativa induzidaporácidotrinitrobenzenosulfônicoemratos. Botucatu:InstitutodeBiociências,UniversidadeEstadual Paulista;2008.

8. Manche ˜no-CorvoP,FranquesaM,RosaO,RamírezC, García-BenzaquénL,FernándezV,etal.Adipose mesenchymalstromalcellfunctionisnotaffectedby MethotrexateandAzathioprine.BioresOpenAccess. 2013;26:431–9.

9.DalalJ,GandyK,DomenJ.Roleofmesenchymalstemcell therapyinCrohn’sdisease.PediatrRes.2012;71:445–51. 10.Gonzalez-ReyE,AndersonP,GonzálezMA,RicoL,BüscherD,

DelgadoM.Humanadultstemcellsderivedfromadipose tissueprotectagainstexperimentalcolitisandsepsis.Gut. 2009;58:1–6.

11.AndoY,InabaM,SakaguchiY,IsudaM,QaunGK,OmaeM, etal.Subcutaneousadiposetissue-derivedstemcells facilitatecolonicmucosalrecoveryfrom2,4,6-trinitrobenzene sulfonicacid(TNBS)-inducedcolitisinrats.InflammBowel Dis.2008;14:826–38.

12.TanakaF,TominagaK,OchiM,TanigawaT,WatanabeT, FujiwaraY,etal.Exogenousadministrationofmesenchymal stemcellsamelioratesdextransulfatesodium-inducedcolitis viaanti-inflammatoryactionindamagedtissueinrats.Life Sci.2008;83:771–9.

13.MorrisGP,BeckPL,HerridgeMS,DepewWT,SzewczukMR, WallaceJL.Hapten-inducedmodelofchronicinflammation andulcerationintheratcolon.Gastroenterology.

1989;96:795–803.

14.BellCJ,GallDG,WallaceJL.Disruptionofcolonicelectrolyte transportinexperimentalcolitis.AmJPhysiol.

1995;268:G622–30.

15.AndersonME.Determinationofglutathioneandglutathione disulfideinbiologicalsamples.MethodEnzymol.

1985;113:548–55.

16.KrawiszJE,SharonP,StensonWF.Quantitativeassayfor acuteintestinalinflammationbasedonmyeloperoxidase activity.Assessmentofinflammationintheratandhamster model.Gastroenterology.1984;87:1344–50.

17.DominiciM,LeBlancK,MuellerI,Slaper-CortenbachI,Marin F,KrauseD,etal.Minimalcriteriafordefiningmultipotent mesenchymalstromalcells.TheInternationalSocietyfor CellularTherapypositionstatement.Cytotherapy. 2006;8:315–7.

18.MizunoH.Adipose-derivedstemcellsfortissuerepairand regeneration:tenyearsofresearchandaliteraturereview.J NipponMedSch.2009;76:56–66.

19.RenY,WuH,ZhouX,WenJ,JinM,CangM,etal.Isolation, expansion,anddifferentiationofgoatadipose-derivedstem cells.ResVetSci.2012;93:404–11.

20.StroberW,FussI,MannonP.Thefundamentalbasisof inflammatoryboweldisease.JClinInvest.2007;117: 514–21.

21.WegmannM,KämpenA,WeberS,SeyberthHW,Köckerling A.Effectofhydroxyeicosatetraenoicacidson

furosemide-sensitivechloridesecretioninratdistalcolon.J PharmacolExpTher.2000;295:133–8.

22.ScarminioV,FruetAC,WitaicenisA,RallVLM,DiStasiLC. Dietaryinterventionwithgreendwarfbananaflour(Musasp AAA)preventsintestinalinflammationina

trinitrobenzenesulfonicacidmodelofratcolitis.NutrRes. 2012;32:202–9.

23.Castelo-BrancoMTL,SoaresIDp,LopesDV,BuongustoF, MartinussoCA,RisarioAJr,etal.Intraperitonealbutnot intravenouscryopreservedmesenchymalstromalcellshome totheinflamedcolonandameliorateexperimentalcolitis. PLOSONE.2012;7:e33360.

24.KuoTK,HungSP,ChuangCH,ChenCT,ShihYR,FangSC, etal.Stemcelltherapyforliverdisease:parameters governingthesuccessofusingbonemarrowmesenchymal stemcells.Gastroenterology.2008;134:2111–21.

25.LuchiniAC,OliveiraDMC,PellizzonCH,DiStasiLC,GomesJC. Relationshipbetweenmastcellsandthecolitiswithrelapse inducedbytrinitrobenzesulphonicacidinWistarrats.Mediat Inflamm.2009:1–7.

(8)

27.AsariS,ItakuraS,RawsonJ,ItoT,TodorovI,NairI,etal. Mesenchymalstemcellsfacilitatemixedhematopoietic chimerisminductionandpreventonsetofdiabetesinNOD mice.Pancreas.2011;40:846–54.

28.LiuK,ChenY,ZengY,XuL,LiuD,ChenH,etal.Coinfusionof mesenchymalstromalcellsfacilitatesplateletrecovery withoutincreasingleukemiarecurrenceinhaploidentical hematopoieticstemcelltransplantation:Arandomized, controlledclinicalstudy.StemCellsDev.2011;20:1679–85.

29.HoshinoA,KawamuraY,YasuharaM,Toyama-SorimachiN, YamamotoK,MatsukawaA,etal.InhibitionofCCL1–CCR8 interactionpreventsaggregationofmacrophagesand developmentofperitonealadhesions.JImmunol. 2007;178:5296–304.

Referências

Documentos relacionados

The animals were divided into the following groups: control group, without surgery and US therapy; tenotomy group, with tenotomy of the Achilles tendon and without US therapy;

We divided the animals in two groups: group A, control, with five animals, and group B, experience, with ten animals that received enteral glutamine two days before sepsis

The animals were randomly divided into ive experimental groups of seven rats each: an I/R group, in which the animals were subjected to 2 h of hind-limb ischemia, induced by

Methods: The study compared 42 female dogs ( Canis familiaris ), divided into 2 groups of 21 animals: Group I (control) – submitted to bowel preparation – and Group II (study)

The animals were randomly divided into four groups, an experimental and a control group (CO), for each of the two models used in the study, intraperitoneal Carbon tetrachlo- ride

Experimental protocol: the animals were randomly allocated into four treatment groups: I – Infected untreated control group; II - Infected treated group with GelFrMeOH; III

Resultados: A lista final adaptada para a realidade portuguesa inclui 184 medicamentos potencialmente inapropriados (dos quais 178 são substâncias ativas, cinco são classes

Three weeks after cell therapy, electrocardiographic parameters in the groups treated with fresh and cryopre- served hUCB cells were typical of infarcted animals..